Cardiac transplantation is currently the preferred long-term treatment of eligible patients with end-stage advanced heart failure. The availability of donor hearts is limited and not all patients may tolerate cardiac transplantation. Implantable left ventricular...
Left ventricular assist device (LVAD) is considered an alternative to transplantationin end stage acute or chronic left ventricular congestive heart failure (HF). Use of LVAD improves the allocation of transplants alleviating the shortage of donors. The target...
The objective of this health technology policy assessment was to determine the effectiveness and cost-effectiveness of using implantable ventricular assist devices in the treatment of end-stage heart failure. Heart failure is a complex syndrome that impairs the...
Left ventricular assist devices help keep blood flowing through the body by assisting a specific chamber in the hearts of patients with severe heart failure. A left ventricular assist device can be implanted as a last resort for patients with severe heart...
Search for
Full reports
Guidelines
Other
Rapid assessments
Review papers